- Home
- IGIC vs MDXG Comparison
IGIC vs MDXG Comparison
Compare IGIC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGIC
- MDXG
- Stock Information
- Founded
- IGIC 2001
- MDXG 2006
- Country
- IGIC Jordan
- MDXG United States
- Employees
- IGIC N/A
- MDXG N/A
- Industry
- IGIC Property-Casualty Insurers
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- IGIC Finance
- MDXG Health Care
- Exchange
- IGIC Nasdaq
- MDXG Nasdaq
- Market Cap
- IGIC 1.1B
- MDXG 877.4M
- IPO Year
- IGIC N/A
- MDXG N/A
- Fundamental
- Price
- IGIC $23.29
- MDXG $6.33
- Analyst Decision
- IGIC Buy
- MDXG Strong Buy
- Analyst Count
- IGIC 2
- MDXG 2
- Target Price
- IGIC $31.50
- MDXG $11.50
- AVG Volume (30 Days)
- IGIC 142.7K
- MDXG 842.0K
- Earning Date
- IGIC 08-05-2025
- MDXG 07-30-2025
- Dividend Yield
- IGIC 0.43%
- MDXG N/A
- EPS Growth
- IGIC 1.83
- MDXG N/A
- EPS
- IGIC 2.73
- MDXG 0.27
- Revenue
- IGIC $537,909,000.00
- MDXG $352,375,000.00
- Revenue This Year
- IGIC $6.05
- MDXG $9.55
- Revenue Next Year
- IGIC $7.01
- MDXG $11.43
- P/E Ratio
- IGIC $8.73
- MDXG $23.26
- Revenue Growth
- IGIC 5.21
- MDXG 5.34
- 52 Week Low
- IGIC $14.86
- MDXG $5.47
- 52 Week High
- IGIC $27.76
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- IGIC 50.63
- MDXG 47.21
- Support Level
- IGIC $23.21
- MDXG $6.57
- Resistance Level
- IGIC $24.24
- MDXG $6.85
- Average True Range (ATR)
- IGIC 0.49
- MDXG 0.29
- MACD
- IGIC 0.04
- MDXG 0.07
- Stochastic Oscillator
- IGIC 49.20
- MDXG 39.50
About IGIC International General Insurance Holdings Ltd.
International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.